Evidence map›Paper›PMID 29260342›Full record

ArticleNeurosurgical review2018

Predictors for a further local in-brain progression after re-craniotomy of locally recurrent cerebral metastases.

Marcel A Kamp, Igor Fischer, Maxine Dibué-Adjei, Christopher Munoz-Bendix, Jan-Frederick Cornelius, Hans-Jakob Steiger, Philipp J Slotty, Bernd Turowski, Marion Rapp, Michael Sabel

Abstract read
PubMed Publisher
In one paragraph

Article in Neurosurgical review, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.0field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marcel A KampDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany. MarcelAlexander.Kamp@med.uni-duesseldorf.de.
Igor FischerDivision of Informatics and Statistics, Department of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Maxine Dibué-AdjeiDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Christopher Munoz-BendixDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Jan-Frederick CorneliusDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Hans-Jakob SteigerDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Philipp J SlottyDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Bernd TurowskiInstitute for Diagnostic and Interventional Radiology Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Marion RappDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Michael SabelDepartment of Neurosurgery, Medical Faculty, Heinrich Heine University, Moorenstraße 5, D-40225, Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Treatment of recurrent cerebral metastases is an emerging challenge due to the high local failure rate after surgery or radiosurgery and the improved prognosis of patients with malignancies. A total of 36 patients with 37 metastases who underwent surgery for a local in-brain progression of a cerebral metastasis after previous metastasectomy were retrospectively analyzed. Degree of surgical resection on an early postoperative MRI within 72 h after surgery was correlated with the local in-brain progression rate and overall survival. Complete surgical resection of locally recurrent cerebral metastases as confirmed by early postoperative MRI could only be achieved in 37.8%. Detection of residual tumor tissue on an early MRI following recurrent metastasis surgery correlated with further local in-brain progression when defining a significance level of p = 0.05 but not after Šidák or Bonferroni significance level correction for multiple testing: However, definite local tumor control could finally be achieved in 91.9% after adjuvant therapy. Overall survival after recurrent metastasectomy was significantly higher as predicted by diagnosis-specific graded prognostic assessment (12.9 ± 2.3 vs. 8.4 ± 0.7 months; p < 0.0001). However, our series involved a limited number of heterogeneous patients. A larger, prospective, and controlled study is required. Considering the adequate local tumor control achieved in the vast majority of patients, surgery of recurrent metastases may represent one option in a multi-modal treatment approach of patients suffering from locally recurrent cerebral metastases.

Indexed as

AdultAgedBrain NeoplasmsChemoradiotherapy, AdjuvantCraniotomyFemaleHumansMagnetic Resonance ImagingMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm, ResidualNeurosurgical ProceduresPredictive Value of TestsPrognosisReoperationMetastasisPostoperative MRIRecurrenceRecurrent metastasisResectionSurgery

Identifiers

PMID29260342
OpenAlexW2776058405

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.